992 相關公司查詢結果

台灣浩鼎 (OBI Pharma Inc.) 是一已推進至臨床階段的全球性癌症新藥公司，除設於台灣之企業總部及研發中心外，在美國和澳洲均有子公司。它是由美國知名的成功生技創業家張念慈博士 (Dr. Michael Chang) 於2002年所創立，2012年公開發行，2015年在台北櫃買中心正式上櫃交易 (TWO.4174)。 台灣浩鼎專注於癌症療法的創新與研發，旨在開發首創型 (first-in-class) 及同類最佳(best-in-class) 的突破型新藥，希望以「台灣製造」品牌，行銷全世界，並為醫療需求尚未被滿足的患者，提供新的治療選擇。 OBI 核心價值，除了極具前景的 Globo 系列 (如 Globo H) 癌症治療疫苗外，更聚焦於提供患者一系列獨特的抗體藥物複合體 (ADC) 新藥。 這些不斷擴展的產品組合，包括以TROP2、Nectin4、HER2 等一系列癌症標靶所開發的 ADC 產品。它們均以浩鼎獨家開發的兩個 ADC 技術平台所構建。兩個平台各具特色，都可「量身訂製」各種ADC；透過抗體醣位點的修飾，可精準將小分子藥物鏈接，憑藉此「即插即用」的策略及平台放大生產之潛力，使得 ADC 開發相對簡單而有效率。 OBI 正致力於將其擁有的 ADC 技術平台商業化，並期待與生技和製藥公司合作，實現首創型 (first-in-class) 和同類最佳 (best-in-class) 候選藥物的進一步開發。 OBI Pharma Inc. (OBI) is a global clinical stage oncology company that is headquartered in Taiwan. The company also has subsidiaries in the United States and Australia. It was founded in 2002 by Dr. Michael Chang, an accomplished biotech entrepreneur in the United States. Its stocks were issued publicly in 2012. Subsequently, the company was successfully listed on the Taipei Exchange (TWO. 4174) in 2015. OBI focuses on innovative research and development for cancer therapies and aims to develop “first-in-class” and “best-in-class” ground-breaking drugs. It aspires to market these drugs worldwide with a “Made in Taiwan” branding and to provide new treatment options for patients with unmet medical needs. The core value of OBI lies in its passion to develop and deliver a portfolio of unique antibody-drug conjugates (ADC) drugs for patients, in addition to its promising Globo series (e.g., Globo H) of cancer therapeutic vaccines. This evolving portfolio includes a spectrum of cancer targets, such as TROP2, Nectin4, HER2, etc. These ADCs are built based on two distinct ADC technology platforms, each with different characteristics. Both platforms are customizable and offer a “plug-and-play” advantage through a specialized site-specific conjugation using a proprietary enzyme. With the added value of scalability, these “plug-and-play” technology platforms enable ADC development to be relatively simple and efficient. OBI is interested in commercializing its ADC technology platforms and looks forward to collaborating with biotech and pharmaceutical companies by enabling “first-in-class” and “best-in-class” therapeutic candidates for further development.

Lenovo (HKSE: 992) (ADR: LNVGY) is a US$62 billion revenue global technology powerhouse, ranked #171 in the Fortune Global 500, employing 77,000 people around the world, and serving millions of customers every day in 180 markets. Focused on a bold vision to deliver smarter technology for all, Lenovo has built on its success as the world’s largest PC company by further expanding into growth areas that fuel the advancement of ‘New IT’ technologies (client, edge, cloud, network, and intelligence) including server, storage, mobile, software, solutions, and services. This transformation together with Lenovo’s world-changing innovation is building a more inclusive, trustworthy, and smarter future for everyone, everywhere. To find out more visit https://www.lenovo.com Lenovo是一家營業額達600億美元，名列《財富》世界500大，業務遍及180個市場的全球化科技企業。 我們專注於“Smarter Technology for All”的願景，每天為數百萬名客戶提供智慧化裝置與基礎架構，並幫助他們打造智慧化解決方案、服務與軟體，期待攜手成就一個更具包容性、更值得信賴且可持續發展的數位化未來。

TWL提供專屬寬敞乾淨施工環境、專業接待室、VIP貴賓休息室 實裝車展示 同樣的價格，您值得更舒適的選擇! TWL台灣碳纖 專業高品質真空石墨碳纖空力套件品牌 服務項目: 保時捷718、981 Cayman、Boxster & GTS、GT4RS taycan GT 992 911 車系 法拉力 488 車系 麥拉倫 540c 570s 570gt車系 特斯拉 Model 3 SR LR PERFORMANCE ModelY 外觀升級空力套件 Benz、BMW Lexus 各式汽車外觀改裝套件 TWL讓你的車更有價值! 我們重視每一位員工，除了有良好工作環境、也提供學習及成長的空間，歡迎優秀的朋友一起加入「台灣碳纖有限公司」的工作行列。

就是個在網路上賣水晶的公司，預計年底會開實體店。 老闆之前是知名餐飲電商平台高管，後來辭職創立這間公司，經營不到1年半，蝦皮獲取44000個真實粉絲、超過3000個真實評價，好評率高達99.992%，專注高品質水晶產品銷售。